Leptospirosis and COVID-19 Co-Infection Manifesting as an Enhanced Thrombotic Phenomenon

authors:

avatar Yudhyavir Singh , * , avatar Abhishek Singh 1 , avatar Kapil Soni , avatar Anjan Trikha

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

how to cite: Singh Y, Singh A, Soni K, Trikha A. Leptospirosis and COVID-19 Co-Infection Manifesting as an Enhanced Thrombotic Phenomenon. J Cell Mol Anesth. 2022;7(2):e149705. https://doi.org/10.22037/jcma.v7i2.36618.

Abstract

Clinical manifestations of COVID-19 range from mild self-limiting illness to multi-organ dysfunction and acute respiratory distress syndrome (ARDS). Leptospirosis too manifests as mild or asymptomatic infection and only small number of patients progress to ARDS and develop systemic manifestation. COVID-19 and leptospira co infection can have fatal outcome because of augmented pathophysiological manifestations of both the disease. We here describe a case of leptospira and COVID-19 coinfection in a patient who had poor outcomes due to multi-organ involvement.